These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12681973)

  • 1. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease).
    Mannucci PM; Karimi M; Mosalaei A; Canciani MT; Peyvandi F
    Haematologica; 2003 Apr; 88(4):454-8. PubMed ID: 12681973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
    Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis).
    Mannucci PM; Vanoli M; Forza I; Canciani MT; Scorza R
    Haematologica; 2003 Aug; 88(8):914-8. PubMed ID: 12935979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
    Peyvandi F; Ferrari S; Lavoretano S; Canciani MT; Mannucci PM
    Br J Haematol; 2004 Nov; 127(4):433-9. PubMed ID: 15521921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
    Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura.
    Gao WQ; Su J; Bai X; Wang ZY; Ruan CG
    Chin Med J (Engl); 2004 Jun; 117(6):818-22. PubMed ID: 15198879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
    Mannucci PM; Capoferri C; Canciani MT
    Br J Haematol; 2004 Jul; 126(2):213-8. PubMed ID: 15238142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
    Studt JD; Kremer Hovinga JA; Alberio L; Bianchi V; Lämmle B
    Swiss Med Wkly; 2003 Jun; 133(23-24):325-32. PubMed ID: 12923683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome.
    Hunt BJ; Lämmle B; Nevard CH; Haycock GB; Furlan M
    Thromb Haemost; 2001 Jun; 85(6):975-8. PubMed ID: 11434704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].
    Hulstein JJ; Rison CN; Kappers-Klunne MC; Hene RJ; Franx A; de Groot PG; Brand A; Fijnheer R
    Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1972-6. PubMed ID: 15524133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
    Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases.
    Franchini M; Montagnana M; Targher G; Lippi G
    Semin Thromb Hemost; 2007 Nov; 33(8):787-97. PubMed ID: 18175284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children.
    Kavakli K; Canciani MT; Mannucci PM
    Pediatr Hematol Oncol; 2002; 19(7):467-73. PubMed ID: 12217192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
    Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies.
    Oleksowicz L; Bhagwati N; DeLeon-Fernandez M
    Cancer Res; 1999 May; 59(9):2244-50. PubMed ID: 10232615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.